Alyeska Investment Group’s Zevra Therapeutics ZVRA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q3 | – | Sell |
-26,721
| Closed | -$748K | – | 482 |
|
|
2019
Q2 | $748K | Sell |
26,721
-67,207
| -72% | -$1.88M | 0.01% | 347 |
|
|
2019
Q1 | $2.51M | Sell |
93,928
-20,135
| -18% | -$538K | 0.03% | 244 |
|
|
2018
Q4 | $3.25M | Buy |
114,063
+92,079
| +419% | +$2.62M | 0.05% | 240 |
|
|
2018
Q3 | $1.69M | Sell |
21,984
-33,246
| -60% | -$2.55M | 0.02% | 291 |
|
|
2018
Q2 | $5.74M | Sell |
55,230
-556
| -1% | -$57.8K | 0.05% | 250 |
|
|
2018
Q1 | $7.05M | Sell |
55,786
-6,235
| -10% | -$788K | 0.06% | 242 |
|
|
2017
Q4 | $4.02M | Hold |
62,021
| – | – | 0.03% | 256 |
|
|
2017
Q3 | $3.67M | Buy |
62,021
+1,107
| +2% | +$65.5K | 0.03% | 294 |
|
|
2017
Q2 | $3.9M | Sell |
60,914
-1,347
| -2% | -$86.2K | 0.03% | 284 |
|
|
2017
Q1 | $4.88M | Sell |
62,261
-160
| -0.3% | -$12.5K | 0.04% | 307 |
|
|
2016
Q4 | $2.95M | Buy |
62,421
+1,963
| +3% | +$92.6K | 0.02% | 357 |
|
|
2016
Q3 | $4.34M | Buy |
60,458
+9,666
| +19% | +$694K | 0.04% | 323 |
|
|
2016
Q2 | $3.23M | Buy |
50,792
+24,861
| +96% | +$1.58M | 0.03% | 331 |
|
|
2016
Q1 | $6.02M | Sell |
25,931
-2,096
| -7% | -$486K | 0.06% | 269 |
|
|
2015
Q4 | $8.91M | Buy |
28,027
+9,888
| +55% | +$3.14M | 0.09% | 219 |
|
|
2015
Q3 | $5.63M | Buy |
18,139
+2,092
| +13% | +$649K | 0.07% | 239 |
|
|
2015
Q2 | $4.72M | Buy |
+16,047
| New | +$4.72M | 0.05% | 262 |
|